ArticleCancer immunology, immunotherapy : CII2026

Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.

Moritz Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.